Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Precision medicine in AML: overcoming resistance
Samuel Urrutia
, Koichi Takahashi
Siteman Cancer Center
Section of Bone Marrow Transplant & Leukemia
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Precision medicine in AML: overcoming resistance'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Isocitrate Dehydrogenase 1 (IDH1)
100%
Precision Medicine
100%
Resistance Mechanisms
100%
Overcoming Resistance
100%
B-cell Lymphoma 2 (Bcl-2)
50%
Acute Myeloid Leukemia
50%
Therapeutic Approaches
50%
Strategies to Overcome
50%
FMS-like Tyrosine Kinase 3 (FLT3)
50%
Disease Phenotype
50%
Genetic Drivers
50%
Molecular Targeted Therapy
50%
Biological Underpinnings
50%
Biological Vulnerability
50%
Non-target-site Resistance
50%
Medicine and Dentistry
Clinician
100%
Acute Myelogenous Leukemia
100%
Acute Myeloid Leukemia
100%
Personalized Medicine
100%
Molecularly Targeted Therapy
100%
Diseases
100%